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1. Introduction 
Laparoscopy-assisted local injection of chemotherapeutic agents is not yet considered as a 
standard treatment for ectopic pregnancy. Herein, we demonstrated cases of cesarean scar 
pregnancy and ovarian ectopic pregnancy successfully treated with trans-vaginal 
sonography-guided local injection of etoposide. Furthermore, we evaluated the efficacy of 
laparoscopic local injection of etoposide compared with methotrexate on tubal pregnancy 
treatment. With the aid of laparoscopic injection, local etoposide treatment offers a precise 
localization and minimally invasive approach to the management of ectopic pregnancies. 
Compared to the conventional way to treat ectopic pregnancy using methotrexate, local 
injection of etoposide is considered to be a high-success rate, low-risk, and less-limitation 
option for such types of ectopic pregnancies with careful selection of cases. 
2. Current opinion and therapeutic strategy on ectopic pregnancies 
Ectopic pregnancy is a complication of pregnancy in which the fetus implants outside the 
endometrial cavity, which ultimately ends in death of the fetus. It constitutes 1.6% of all 
pregnancies (Lurie, 1992). Most ectopic pregnancies are located in the fallopian tube, but the 
implantation can also occur in the cervix, ovaries, abdomen, and even cesarean scars. 
Ectopic pregnancy is usually not viable. If left untreated, half of ectopic pregnancies will 
resolve without treatment and presents as the tubal abortions. Ectopic pregnancies are 
considered as a dangerous health problem for women of childbearing age because of the 
internal bleeding as a common complication. In fact, maternal mortality is 0.14% in cases of 
ectopic pregnancy (Lurie, 1992; Te Linde, Rock, & Thompson, 1997). 
Within various forms of ectopic pregnancies, cesarean scar pregnancy is a rare form of 
ectopic implantation. The pathogenesis is thought to be a normal fertilization followed by 
implantation at the ecchymotic lesion site which is bulging from the uterine wall at the 
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cesarean scar. If a caesarean scar pregnancy continues developing to second or third 
trimesters, there might be risks of uterine rupture or catastrophic hemorrhage which may 
cause serious maternal morbidity and loss of fertility. Differential diagnosis and early 
diagnosis of such an ectopic pregnancy is now more feasible because of the use of high-
resolution transvaginal sonography and the availability of sensitive -hCG assay. 
Primary ovarian pregnancy is also considered as an uncommon form of ectopic 
implantation and represents 0.5%–3% of all ectopic pregnancies. The pathogenic mechanism 
is thought to be fertilization occurring outside the tube, followed by implantation within the 
ovary. Differential diagnosis of an ovarian pregnancy from a tubal pregnancy has been a 
challenge in the past. However, due to the improvement of high-resolution transvaginal 
sonography and the availability of sensitive -hCG assay, an early diagnosis of an ovarian 
pregnancy is now more feasible. 
Once diagnosed, the conventional treatment of ectopic pregnancy is surgical approach. The 
traditional method for management of a cesarean scar pregnancy is surgical removal of the 
ectopic pregnancy (Arslan, et al., 2005; C. B. Wang & Tseng, 2006; Y. L. Wang, Su, & Chen, 
2006). There have been few reports showing that cesarean scar pregnancies were successfully 
treated by local injection of methotrexate (Hwu, Hsu, & Yang, 2005; Ravhon, Ben-Chetrit, 
Rabinowitz, Neuman, & Beller, 1997). Similarly, the traditional management mean for ovarian 
pregnancy is surgical removal of the ectopic site, either by ipsilateral oophorectomy or wedge 
resection by laparotomy or laparoscopy(Yen & Wang, 2004). There has been sporadic case 
reports showing that ovarian pregnancy was successfully treated by systemic methotrexate 
injection (Chelmow, Gates, & Penzias, 1994; Field & Faraj, 2005; Habbu & Read, 2006).  
Methotrexate is not yet a first-line treatment for ovarian pregnancy or cesarean scar pregnancy 
even in candidates who meet the criteria for medical treatment (Bagga, Suri, Verma, Chopra, & 
Kalra, 2006; Medical treatment of ectopic pregnancy," 2006). However, the use of systemic 
methotrexate treatment has considered being an option to preserve potential fertility in ectopic 
pregnancy patients (Hung, Jeng, Yang, Wang, & Lan, 1996; Marcovici, Rosenzweig, Brill, Khan, 
& Scommegna, 1994; Timor-Tritsch, et al., 1994). Several risk factors have to be evaluated while 
systemic methotrexate is indicated for the treatment of ectopic pregnancy. The patient should be 
hemodynamically stable, have no severe contraindications to methotrexate. Furthermore, the 
size of the gestation sac should not exceed 3 cm under ultrasound measurement, and the serum 
β-hCG level should not exceed 2000 mIU/mL. In cases of tubal ectopic pregnancy, the presence 
of an embryonic cardiac activity was generally considered to be a contraindication to 
methotrexate therapy (Ory, 1992). Ushakov et al. reported that the side effects of systemic 
methotrexate treatment occurred 15% of the time, which include bone marrow depression, 
stomatitis, anorexia, nausea, vomiting, and diarrhea (Floridon & Thomsen, 1994; Ushakov, 
Elchalal, Aceman, & Schenker, 1997). These contraindications and side effects have become the 
limitations of systemic treatment of methotrexate on ectopic pregnancy.  
AS a result, considering the highly vascularized tissues involved in the surgical procedure and 
the contraindications of systemic therapy, local injection of the chemotherapeutic agents is 
then suggested. There have been few reports showing that ectopic pregnancies were 
successfully treated by local injection of methotrexate or etoposide (C. H. Chen, Wang, & Liu, 
2009; Hwu, et al., 2005; Juan, Wang, Chen, Ma, & Liu, 2008; Ravhon, et al., 1997). With 
laparoscopic local injection, the chemotherapeutic agent such as methotrexate or etoposide 
could be precisely injected into the ectopic implantation. These procedures lead to a significant 
decline in side effects and contribute to the preservation of the patients’ reproductive potential. 
However, comparing to methotrexate, etoposide is not yet a widely used treatment for ectopic 
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pregnancy, and there are still no criteria established. Even in cases of all kinds of ectopic 
pregnancy, the uses of etoposide were reported in less than ten cases since 1990 (C. L. Chen, 
Wang, Chiu, Yang, & Hung, 2002; Juan, et al., 2008; Mantalenakis, et al., 1995; Seki, Kuromaki, 
Takeda, & Kinoshita, 1997; Takashima, et al., 1995). Herein we demonstrated various cases 
including ovarian, CS scar, and tubal pregnancies successfully treated by laparoscopic local 
injection of etoposide with trans-vaginal sonography -assisted localization. Furthermore, since 
etoposide and methotrexate have been applied locally to treat ectopic pregnancy, we 
evaluated the clinical efficacies of local treatment of these two chemotherapeutic agents. 
3. Cases: The treatment of cesarean scar and ovarian pregnancies with 
laparoscopy-assisted local injection of etoposide 
Case I: A 37 year-old-female, gravida 5, para 2 (cesarean section twice), abortion 2, had 
presented with a 8-week history of gestational amenorrhea. She accidentally found herself 
pregnancy and asked for an elective abortion in a local clinic. Her general condition was fair. 
She was considered intra-uterine pregnancy at local clinic and uterine curettage had been 
performed 3 times since she kept suffering from vaginal bleeding after first curettage. She 
came to our hospital for second opinion due to persistent vaginal bleeding. trans-vaginal 
sonography revealed an empty uterus and suggested an ectopic sac of 1.9 × 1.7 cm in diameter 
between anterior wall of uterus and bladder on previous cesarean scar. β-hCG level was 
measured at 572.2 mIU/mL. Based on these findings, a cesarean pregnancy was suspected.  
A laparoscopy was then performed while an ecchymotic lesion (2cm) found bulging from 
the uterine wall at the previous cesarean scar area. The two fallopian tubes and two ovaries 
were intact and normal. Confirmed with trans-vaginal sonography, the mass was indicated  
 
 
Fig. 1. Chemotherapeutic agent was injected into the ectopic sac laparoscopically, followed 
by bipolar electrocoagulation (black arrow). 
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a cesarean scar pregnancy. With the guidance of trans-vaginal sonography to precisely 
estimate the depth of the puncture site to the gestational sac, 100mg of etoposide was 
directly injected into the ectopic sac by laparoscopy (Figure 1). The puncture site was 
immediately sealed by bipolar electro-coagulation. The patient was followed up with serial 
trans-vaginal sonography and -hCG level monitoring. The trans-vaginal sonography 
showed a progressive shrinkage of the mass, and the -hCG levels declined continuously to 
28.1 mIU/mL 9 days after the surgery, and 5.0 mIU/mL 17 days later. The patient 
experienced normal menstruation 45 days after the procedure. 
Case II: A 33-year-old woman, gravida 1, para 0, had presented with a 7-week history of 
gestational amenorrhea and lower abdominal discomfort. Her general condition was fair. 
The serum b-hCG level was measured at 2,765 mIU/mL. The trans-vaginal sonography 
revealed an empty uterus and suggested an ectopic sac of 4.3 by 2.8 cm in diameter in the 
right ovarian region. The fluid in the Douglas pouch measured 2.0 x 1.8 cm in diameter. 
Based on these findings, an ovarian pregnancy was suspected. A laparoscopy was then 
performed. One hundred milliliters of bloody fluid was collected from the cul-de-sac. The 
two fallopian tubes were intact, and the uterus and left ovary were normal. A 4-cm diameter 
bluish and hemorrhagic mass on the right ovary indicated the possibility of an ovarian 
pregnancy. Punch with aspiration and direct injection of 100 mg of etoposide into the 
ectopic sac (Figure 2) was performed and the fluid aspirated from the hemorrhagic sac seen  
 
 
Fig. 2. After local injection of the chemotherapeutic agent, bipolar electro-coagulation was 
used to seal the puncture site. 
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at laparoscopy was sent for pathologic examination, which showed scant chorionic villi and 
granulosa cells (GC) in support of the diagnosis of ovarian pregnancy. The patient was 
followed up with serial trans-vaginal sonography and checking of b-hCG levels. The b-hCG 
levels declined continuously to 37.34 mIU/mL 8 days after surgery and 6.01 mIU/ mL 1 
week later. The patient menstruated 25 days after the procedure. 
The traditional treatments for ectopic pregnancies are considered more invasive procedures. 
Therefore, how to select one of the less invasive procedures to diagnose and treat this rare 
ectopic pregnancy is important. For example, in case I, a deeply implanted cesarean scar 
pregnancy was growing towards the abdominal cavity and bladder, thus we choose 
laparoscopy as a primary mean to approach the cesarean scar pregnancy (Vial, Petignat, & 
Hohlfeld, 2000; C. J. Wang, et al., 2006). Trans-vaginal sonography-guided local injection not 
only offers a precise localization of the injection site, but also offered a minimally invasive 
procedure for the case. Furthermore, local injection of etoposide bypasses the systemic side 
effects of the drug. Taken together, trans-vaginal sonography-guided laparoscopic local 
injection of etoposide for such cases are suggested. 
4. The comparison of etoposide and methotrexate efficacies on tubal 
pregnancy treatment 
Etoposide, an antineoplastic agent, can produce cytotoxic effects by damaging DNA, thereby 
inhibiting or altering DNA synthesis. The drug appears to be cell-cycle dependent and cycle-
phase specific, inducing G2 phase arrest and killing cells in the G2 and late S phases. In 2002, 
Chen et al. successfully used a ultrasound-guided direct injection of etoposide to treat an 
interstitial pregnancy (C. L. Chen, et al., 2002). Based on the finding that etoposide was more 
effective and had fewer side effects in the management of low-risk gestational trophoblastic 
tumor, compared to methotrexate treatment (Matsui, et al., 2005), direct injection of etoposide 
for ectopic pregnancy is considered. Local administration of methotrexate was described in 
several cases (Hung, et al., 1996; Monteagudo, Minior, Stephenson, Monda, & Timor-Tritsch, 
2005; Timor-Tritsch, et al., 1994). On the other aspect, the use of etoposide in ectopic pregnancy 
is relatively new. The standardized protocol is not yet available, although there were few cases 
used ultrasound-guided direct injection of etoposide to treat ectopic pregnancy (C. H. Chen, et 
al., 2009; C. L. Chen, et al., 2002; Juan, et al., 2008). 
From 1993 through 2009, 28 patients of tubal pregnancy received local injection of 
methotrexate or etoposide were documented. In all cases, age, body weight, hemoglobin 
level and the operation time were recorded. The gestational age, cardiac activity of the 
conceptus, β-hCG levels before and after the treatment, and the occurrence and outcomes of 
subsequent pregnancies were evaluated. Among the enrolled patients, methotrexate has 
been administered locally to 11 patients and etoposide to 17 patients. In group (I), 50 mg of 
etoposide was injected into the ectopic sites by laparoscopy. In group (II), 50 mg of 
methotrexate was applied. All patients were followed up with serial β-hCG level 
monitoring. None of the patients had significant side effects of systemic treatment of the 
agents. More than 50% of the patients had a gestational size of greater than 30 mm. 
The administration of methotrexate locally was chosen to avoid the adverse effect of 
systemic administration of methotrexate. Hung et al. observed that methotrexate alone or 
combined with procedures such as curettage or cervical tamponade is effective in ectopic 
pregnancies of up to 12 weeks (Hung, et al., 1996). In this survey, the median (range) of the 
time it took to decline to the non-pregnant β-hCG level (undetectable or below 5 mIU/mL) 
of methotrexate injection group was longer than the etoposide injection group, though not 
significant difference is observed (Table 1). 
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Table 1. Baseline characteristics of the enrolled women 
There is still no consensus about the most appropriate treatment for ectopic pregnancy. 
Therefore, large prospective randomized trials are still needed to establish common 
selection criteria, dosage, and length of follow up of the therapies. Furthermore, to increase 
the success rate, experiences in invasive ultrasound-guided procedures is indeed crucial for 
the success of this treatment option, but careful selection of patients and their compliance is 
also important. In this study, local injection of 50 mg etoposide to treat ectopic pregnancy 
was evaluated and compared with local injection of methotrexate. In women who desire 
future pregnancy, these two types of conservative treatment may be an acceptable and 
promising alternative in the management of ectopic pregnancy. Taken together, a local 
injection of etoposide might be a good choice for ectopic pregnancy. 
5. Summary 
The advances in ultrasound equipment and easy access to quantitative β-hCG have made 
the diagnosis of early ectopic pregnancies possible. The efforts to improve the management 
of ectopic pregnancy have also stimulated many investigators to design new approaches to 
treat early ectopic pregnancy. This enables successful application of conservative therapies 
such as local treatment of chemotherapeutic agents such as etoposide or methotrexate. Not 
like methotrexate, etoposide is not yet considered as a standard treatment for ectopic 
pregnancy while there are still no criteria established. As compared to local methotrexate 
treatment, local etoposide treatment has the advantages of better efficacy to treat patients 
with higher β-hCG level. With the aid of laparoscopic injection, local treatment of etoposide 
is considered as a precise localization and the minimally invasive option to the management 
of ectopic pregnancy. 
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